How is AI revolutionizing regulatory submissions in biotech and pharma? Find out in this episode of the AI in Action podcast, featuring Brandon Rice, Chief Product Officer at Weave.
Brandon shares insights on:
✔️ AI-powered automation in regulatory filings to accelerate drug approvals
✔️ Streamlining FDA submissions—cutting time and costs dramatically
✔️ Customer-driven product development for seamless compliance workflows
✔️ Expanding regulatory support from preclinical IND to clinical-stage submissions
✔️ Scaling AI-powered regulatory workbenches to support biotech, pharma, CROs, and consultants
Weave’s AI-native regulatory automation platform, AutoIND, is redefining how life sciences companies prepare, manage, and submit regulatory documents. From IND to BLA, NDA, and beyond, Weave is building an AI-driven regulatory workbench for the entire therapy lifecycle.
🎧 Listen now to learn how Weave is shaping the future of regulatory automation!
